Dihydrocodeine Bitartrate 16mg Cough Suppressant Capsules from Japan
Capsules containing dihydrocodeine bitartrate, a semi-synthetic opioid alkaloid derivative, for cough suppression and pain relief in measured doses. HTS 3004.49.0060 applies to this retail-packaged therapeutic product with alkaloids, distinct from veterinary or hormone meds.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Declare as controlled substance; provide import/export license from DEA
• Validate child-resistant packaging compliance under Poison Prevention Act